451 related articles for article (PubMed ID: 23767942)
1. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients.
Prasad N; Gupta P; Jain M; Bhadauria D; Gupta A; Sharma RK; Kaul A
Exp Clin Transplant; 2013 Jun; 11(3):215-21. PubMed ID: 23767942
[TBL] [Abstract][Full Text] [Related]
2. Allograft diabetic nephropathy may progress to end-stage renal disease.
Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
[TBL] [Abstract][Full Text] [Related]
3. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
[TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy after renal transplantation. Clinical and pathologic features.
Hariharan S; Smith RD; Viero R; First MR
Transplantation; 1996 Sep; 62(5):632-5. PubMed ID: 8830828
[TBL] [Abstract][Full Text] [Related]
5. De novo diabetic nephropathy with functional impairment in a renal allograft.
Gimenez LF; Watson AJ; Burrow CR; Olson JL; Klassen DK; Cooke CR
Am J Nephrol; 1986; 6(5):378-81. PubMed ID: 3548353
[TBL] [Abstract][Full Text] [Related]
6. Rapid onset of diabetic nephropathy in three renal allografts despite normoglycemia.
Wojciechowski D; Onozato ML; Gonin J
Clin Nephrol; 2009 Jun; 71(6):719-24. PubMed ID: 19473643
[TBL] [Abstract][Full Text] [Related]
7. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
Racca MA; Novoa PA; RodrÃguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
[TBL] [Abstract][Full Text] [Related]
8. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
Haas M
Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
[TBL] [Abstract][Full Text] [Related]
9. Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts.
Kim H; Cheigh JS
Korean J Intern Med; 2001 Jun; 16(2):98-104. PubMed ID: 11590909
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.
Gelens MA; Steegh FM; van Hooff JP; van Suylen RJ; Nieman FH; van Heurn LW; Peutz-Kootstra CJ; Christiaans MH
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1010-7. PubMed ID: 22490875
[TBL] [Abstract][Full Text] [Related]
11. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
[TBL] [Abstract][Full Text] [Related]
12. Kidney allograft failure in the steroid-free immunosuppression era: A matched case-control study.
Alkadi MM; Kim J; Aull MJ; Schwartz JE; Lee JR; Watkins A; Lee JB; Dadhania DM; Seshan SV; Serur D; Kapur S; Suthanthiran M; Hartono C; Muthukumar T
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28921709
[TBL] [Abstract][Full Text] [Related]
13. Causes of late transplant failure in cyclosporine-treated kidney allograft recipients.
Moroni G; Binda V; Quaglini S; Sacchi L; Raffiotta F; Cosa F; Montagnino G; Favi E; Messa P; Ponticelli C
Clin Exp Nephrol; 2019 Aug; 23(8):1076-1086. PubMed ID: 31016431
[TBL] [Abstract][Full Text] [Related]
14. The natural history of chronic allograft nephropathy.
Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
[TBL] [Abstract][Full Text] [Related]
15. T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.
Yadav B; Prasad N; Agrawal V; Jain M; Agarwal V; Jaiswal A; Bhadauria D; Sharma RK; Gupta A
Exp Clin Transplant; 2015 Apr; 13(2):145-51. PubMed ID: 25871366
[TBL] [Abstract][Full Text] [Related]
16. Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.
Merville P
Drugs; 2005; 65(5):615-31. PubMed ID: 15748097
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
Rodriguez Cubillo B; Rodriguez B; Calvo M; de la Manzanara V; Bautista J; Perez-Flores I; Calvo N; Moreno A; Shabaka A; Delgado J; Sanchez-Fructuoso AI
Transplant Proc; 2016 Nov; 48(9):2956-2958. PubMed ID: 27932117
[TBL] [Abstract][Full Text] [Related]
18. Higher Incidence of Renal Allograft Glomerulonephritis in Living-Related Donor Kidney Transplantation.
Deng R; Dai Y; Zhang H; Liu L; Li J; Xiong Y; Deng S; Fu Q; Wang C
Transplant Proc; 2018 Oct; 50(8):2421-2425. PubMed ID: 30316370
[TBL] [Abstract][Full Text] [Related]
19. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M
Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
